Bacillary Dysentery: Causes, Symptoms, and Prevention

Bacillary dysentery is an intestinal infection caused by bacteria in the genus Shigella, and it remains one of the most common causes of bloody diarrhea worldwide. The bacteria spread easily through contaminated water, food, or direct person-to-person contact, and they are remarkably efficient at invading the lining of the large intestine. Even a tiny dose of the organism can trigger illness, which is part of what makes it so persistent in crowded or resource-limited settings. But the story of bacillary dysentery is more complicated than “bad water, bad outcome,” touching on rising drug resistance, surprising routes of transmission, and long-term consequences that researchers are only beginning to quantify.

The Bacteria Behind It

Four species of Shigella cause bacillary dysentery: S. dysenteriae, S. flexneri, S. sonnei, and S. boydii. They are not all equally dangerous or equally common. S. dysenteriae type 1 produces a potent toxin called Shiga toxin and is responsible for the most severe outbreaks, with the highest death rates. S. flexneri is the predominant species in low-income countries and regions with poor sanitation, while S. sonnei tends to dominate in wealthier, more urbanized settings.¹ As countries improve economically, researchers have observed a shift: S. sonnei gradually replaces S. flexneri as the leading cause, a pattern confirmed by surveillance data from both urban and rural regions.²

An interesting wrinkle: genetically, Shigella species are not truly separate from Escherichia coli. Their DNA is roughly 80 to 90 percent similar, and Shigella are essentially strains of E. coli that acquired a specific set of virulence genes carried on a large plasmid.³ They were classified as their own genus decades ago because of how they behave clinically, but from an evolutionary standpoint, the distinction is somewhat artificial. This close relationship also complicates laboratory identification, which matters for diagnosis.

How Shigella Gets Inside You

The classic route of transmission is fecal-oral: someone with the infection sheds the bacteria in their stool, and those bacteria end up in another person’s mouth through contaminated hands, food, or water. What makes Shigella especially troublesome is its infectious dose. While many gut pathogens require hundreds of thousands or millions of organisms to cause illness, Shigella can do so with as few as 10 to 100 bacteria. That low threshold means a lapse in hand hygiene after using the bathroom, or a shared surface in a daycare center, can easily start a chain of infection.

Contaminated water supplies and lack of sanitation infrastructure drive large outbreaks in low-income countries, refugee camps, and disaster-affected areas. But bacillary dysentery is not exclusively a disease of poverty. Outbreaks occur in industrialized countries too, often in institutional settings such as daycare facilities, nursing homes, and prisons where close contact is unavoidable.

Sexual Transmission and High-Risk Groups

A route of transmission that gets less public attention is sexual. In high-income countries, clusters of Shigella infection have been increasingly documented among men who have sex with men (MSM), driven primarily by direct or indirect oral-anal contact. A case-control study in San Francisco found that MSM status was the strongest risk factor for shigellosis among men, with roughly eight times the odds compared to controls, and direct oral-anal contact independently increased risk about sevenfold.⁴ HIV infection was also independently associated, likely because of increased susceptibility rather than exposure alone.

A systematic review of sexually transmitted shigella in MSM identified several associated factors, including living with HIV, having a concurrent sexually transmitted infection, using PrEP, and attending sex-on-premises venues. The review also found that sexually transmitted strains were more likely to be drug-resistant, including strains with reduced susceptibility to azithromycin.⁵ Outbreaks of a primarily clonal strain of S. flexneri serotype 1 have been tracked in cities like Vancouver, placing a substantial burden on healthcare systems through hospital admissions.⁶ Understanding this route matters because prevention messaging targeted only at food and water safety misses a significant proportion of cases in urban, high-income settings.

What Shigella Does Once Inside the Gut

Once swallowed, Shigella bacteria survive the acidic environment of the stomach and reach the large intestine, where they invade the epithelial cells lining the colon. They do this using a molecular syringe, a structure called a type III secretion system, which punctures the host cell membrane and injects proteins that hijack the cell’s own machinery.⁷ These injected proteins force the cell to rearrange its internal skeleton and essentially pull the bacterium inside.⁸

Once inside a cell, Shigella does something particularly clever: it co-opts the cell’s own structural fibers to propel itself through the cell body and push into neighboring cells. The bacteria assemble rocket-like tails of actin filaments behind them, generating enough force to create finger-like protrusions in the cell membrane that the adjacent cell then engulfs.⁹ This cell-to-cell movement lets the bacteria spread through the tissue without ever returning to the outside environment, which helps them dodge the immune system’s antibodies circulating in the gut.

The result of all this invasion is intense inflammation. The immune system responds aggressively, flooding the infected tissue with white blood cells. That inflammatory response is what causes the hallmark symptoms: bloody, mucus-laden diarrhea and severe cramping. Paradoxically, the immune response itself does much of the tissue damage.

Symptoms and How They Progress

Symptoms usually begin one to three days after exposure. Most cases start with watery diarrhea, fever, and abdominal cramps. Within a day or two, the diarrhea in classic dysentery becomes bloody and mucoid, with frequent, painful urges to use the bathroom even when the bowel is nearly empty (a sensation called tenesmus). Stools become small in volume but frequent, sometimes more than 20 times a day.

The severity varies by species. S. sonnei infections tend to be the mildest, often presenting as watery diarrhea without blood and resolving in a few days. S. flexneri and S. dysenteriae typically produce more severe illness. S. dysenteriae type 1, in particular, can cause systemic complications including dangerous electrolyte imbalances and seizures, especially in young children.¹⁰ Dehydration is a constant concern, and in malnourished children in low-income settings, even a moderate case can become life-threatening.

One diagnostic challenge is that the clinical picture of bacillary dysentery overlaps with intestinal amebiasis, caused by the parasite Entamoeba histolytica. Both can produce bloody diarrhea and abdominal pain. However, shigellosis tends to show more white blood cells in the stool (a sign of bacterial infection), whereas amebiasis more often presents with alkaline stool and fewer fecal leukocytes.¹¹ Laboratory testing is needed to distinguish them reliably.

Serious Complications

Most cases of bacillary dysentery resolve without lasting damage, but serious complications do occur. The most dangerous is hemolytic uremic syndrome (HUS), a condition in which the toxin damages blood vessel walls, triggers abnormal blood clotting in small vessels, and leads to kidney failure. HUS develops in roughly 8 percent of people infected with S. dysenteriae type 1 that produces Shiga toxin.¹² The toxin works by shutting down protein production inside cells lining small blood vessels, causing massive cell death, activating clotting inside capillaries, and eventually leading to organ failure.¹³

Reactive arthritis is another recognized complication. Weeks after the gut infection clears, some people develop joint pain, swelling, and sometimes eye inflammation. This is thought to be an immune-mediated reaction rather than direct bacterial invasion of the joints, and it has been documented following infections with S. flexneri, S. sonnei, and even S. dysenteriae type 1.¹⁴ People carrying the HLA-B27 genetic marker are thought to be at higher risk, though reactive arthritis can occur in anyone.

Childhood Stunting and Long-Term Growth

Beyond the acute illness, repeated or severe Shigella infections in early childhood carry consequences that persist long after the diarrhea stops. A systematic review found that Shigella is associated with persistent diarrhea, reduced linear growth, and economic impact on affected families.¹⁵ The greatest losses in height-for-age occurred in children who had cumulative infections over their first two years of life.

There is a hopeful finding embedded in this research, though. When toddlers with Shigella-positive diarrhea received appropriate antibiotic treatment, the growth decline was about four times smaller than in untreated children, suggesting that timely treatment can meaningfully reduce the stunting impact.¹⁶ This finding carries real weight for public health policy in settings where antibiotic access for childhood diarrhea is inconsistent.

Diagnosis Is Harder Than It Sounds

The traditional way to confirm Shigella infection is stool culture: growing the bacteria on selective media in a laboratory. The problem is that stool culture misses a lot of cases. The bacteria are fragile, and samples that sit for even a few hours without proper handling lose viability. In one large study of children with moderate-to-severe diarrhea in low-income countries, a quantitative PCR test targeting a Shigella gene detected 90 percent more cases than conventional culture did.¹⁷

A clinical evaluation of a multiplex real-time PCR assay showed 100 percent sensitivity for detecting Shigella after discrepant results were resolved, compared to culture sensitivity that ranged from about 53 to 77 percent depending on the pathogen.¹⁸ Work in Burkina Faso similarly found that PCR picked up far more Shigella cases than culture, identifying 17 cases where culture found only 5.¹⁹ The implication is that the true burden of Shigella disease has been historically undercounted, and many cases have gone undiagnosed.

Treatment and the Growing Problem of Drug Resistance

Mild shigellosis often resolves on its own with fluids and rest. For moderate-to-severe cases, antibiotics shorten the illness, reduce transmission, and, as noted above, may protect children against growth faltering. The catch is that Shigella has been accumulating resistance to antibiotics at an alarming pace.

Surveillance in Bangladesh found that more than 60 percent of recent Shigella isolates were resistant to three or more standard drugs, with significant increases in resistance to commonly used antibiotics over a decade-long period. Resistance to newer agents like azithromycin and even ceftriaxone had started to appear.²⁰ The situation has only worsened since. A review of global resistance patterns noted that strains resistant to ciprofloxacin, azithromycin, and ceftriaxone simultaneously, the three first-line drugs for infectious diarrhea, have emerged worldwide and spread through travel, trade, and sexual networks. Some strains have even developed resistance to colistin, a last-resort antibiotic.²¹

In France, researchers documented a dramatic rise in extensively drug-resistant S. sonnei beginning around 2015. Genomic analysis traced the lineage to a ciprofloxacin-resistant sublineage that originally developed in South Asia, then acquired azithromycin resistance through plasmid transfer, and finally picked up various genes encoding resistance to third-generation cephalosporins.²² This kind of stepwise accumulation of resistance genes is what makes Shigella a growing concern for clinicians: the treatment options are narrowing, and the bacteria keep adapting.

In malnourished children, zinc supplementation alongside standard treatment has shown benefit. A trial in Bangladesh found that children receiving zinc recovered about 50 percent faster than controls, gained more weight during recovery, and had fewer diarrheal episodes over the following six months.²³ Zinc does not replace antibiotics, but it appears to support gut healing and immune function during and after infection.

Prevention and Its Limits

The classic advice for preventing bacillary dysentery is straightforward: wash your hands with soap after using the toilet and before handling food, drink safe water, and practice proper food hygiene. This advice works. A study that promoted hand washing in households with confirmed Shigella cases found that the secondary infection rate dropped from about 32 percent in control households to 10 percent in the hand-washing group, and symptomatic cases fell from 14 percent to 2 percent.²⁴

But researchers have found that household-level water, sanitation, and hygiene (WASH) interventions have limits. Large cluster-randomized trials, including the WASH Benefits and SHINE studies, showed surprisingly modest effects on diarrheal disease when interventions were implemented at the household level without broader community coverage.²⁵ One study specifically measuring immune markers of Shigella exposure in young children found that intensive household WASH combined with nutrition interventions did not reduce the proportion of children who had been exposed to the bacteria.²⁶ The implication is not that handwashing and clean water are useless, far from it. Rather, Shigella‘s extremely low infectious dose means that even small gaps in community-wide sanitation can sustain transmission, and individual household improvements cannot fully compensate.

For travelers visiting endemic areas, practical prevention includes drinking bottled or boiled water, avoiding raw vegetables and fruit you did not peel yourself, and being diligent about hand hygiene. For MSM, awareness that Shigella can spread through sexual contact is important; barrier methods and hand washing before and after sexual activity reduce risk.

Where Vaccine Development Stands

No licensed Shigella vaccine is available yet, but the field is more active than it has ever been. Multiple candidates are in clinical trials using different approaches, including live-attenuated bacteria, protein-based formulations, glycoconjugate vaccines, and a newer platform called GMMA (generalized modules for membrane antigens).²⁷ A systematic review of 24 clinical trials found that most candidates were safe and generated measurable immune responses. Glycoconjugate vaccines tended to produce longer-lasting antibody responses, while live-attenuated vaccines triggered broader immune activation at the mucosal level, closer to where Shigella actually invades.

The frustration is that only one candidate has made it to a Phase III efficacy trial, and direct comparisons between platforms are difficult because studies have used different dosing schedules, immune markers, and follow-up periods.²⁷ Still, several candidates have advanced into Phase II and III trials across multiple regions.²⁸ Given the worsening antibiotic resistance landscape, a working vaccine would transform the fight against bacillary dysentery. The need is most urgent for children under five in low-income countries, who bear the heaviest burden, but a vaccine could also benefit travelers, military personnel, and MSM communities experiencing outbreaks.

What Shigella Does to the Gut Microbiome

Emerging research suggests that Shigella infection does not just damage the intestinal lining; it reshapes the microbial community living in the gut. An animal study found that oral infection with S. flexneri rapidly and significantly altered the gut microbiota, decreasing the abundance of beneficial bacteria such as Lactobacillus while increasing potentially harmful groups. Probiotic species like Lactobacillus reuteri showed significantly reduced abundance after infection.²⁹ Whether these shifts contribute to the persistent diarrhea and growth problems seen in repeatedly infected children is an active area of investigation, and it raises the question of whether probiotic supplementation could eventually play a role in recovery alongside antibiotics and zinc. That work is still early, but the finding that infection disrupts the gut ecosystem well beyond the acute illness adds another layer to why Shigella carries consequences that outlast the fever and cramping.